Solving data to enable precision diagnostics for all.
Business Model:
Revenue: $0
Employees: 11-50
Address:
City: Cambridge
State: Cambridgeshire
Zip:
Country: United Kingdom
Concr is an emerging software platform to combat cancer. It combines cutting edge machine learning techniques with a deep scientific understanding of tumour progression to accurately predict cancer evolution in response to treatment. This will enable clinicians to adapt treatments proactively, rather than reactively, to prevent treatment resistance and improve treatment efficacy through precision medicine. Concr aims to: • Reduce treatment resistance • Cut the cost of cancer treatment • Enable proactive treatment adaptation • Save lives
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 4/2021 | Seed Round | $0 |
Accelerate@Babraham Avonmore Developments Cambridge Angels group Deep Science Ventures Illumina KQ Labs R42 Group University of Cambridge Enterprise Accelerate@Babraham Avonmore Developments Cambridge Angels group Deep Science Ventures Illumina KQ Labs R42 Group University of Cambridge Enterprise |
4/2021 | Seed Round | 8 | $691.5k |
Accelerate@Babraham Avonmore Developments Cambridge Angels group Deep Science Ventures Illumina KQ Labs R42 Group University of Cambridge Enterprise Accelerate@Babraham Avonmore Developments Cambridge Angels group Deep Science Ventures Illumina KQ Labs R42 Group University of Cambridge Enterprise |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|